The present invention relates to agents capable of inhibiting the binding between Leptin and Neuropilin-1 (NRP 1)and uses thereof in the therapeutic field.
Lire l'articleArchives : Brevets
description brevets
description brevets
The present invention relates to agents capable of inhibiting the binding between Leptin and Neuropilin-1 (NRP 1)and uses thereof in the therapeutic field.
Lire l'article